23.04.2012 - Australian flu drug maker Biota Holdings has agreed to take over U.S. firm Nabi Biopharmaceuticals to create a $258 million group and move to the United States, where investors...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)